Webinar: Diagnosis and Management of Central Sleep Apnea and Cheyne-Stokes Respiration

In this webinar, Dr. Alan R. Schwartz of the University of Pennsylvania Perelman School of Medicine discusses central sleep apnea (CSA)/Cheyne-Stokes respiration (CSR) pathogenesis, polysomnographic manifestations, and clinical impact. Dr. Schwartz also discusses therapeutic approaches to CSA/CSR, including the remedē® System which uses transvenous phrenic nerve stimulation to treat CSA.
Indication for use: The remedē® System is an implantable phrenic nerve stimulator indicated for the treatment of moderate to severe central sleep apnea (CSA) in adult patients. The remedē System is contraindicated for patients with an active infection. Read full indications for use: remede.zoll.co...
(MedEd3111 Rev A)